Satsuma Pharmaceuticals Probability of Future Stock Price Finishing Over 1.10

STSADelisted Stock  USD 1.10  0.01  0.90%   
Satsuma Pharmaceuticals' future price is the expected price of Satsuma Pharmaceuticals instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Satsuma Pharmaceuticals performance during a given time horizon utilizing its historical volatility. Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
  
Please specify Satsuma Pharmaceuticals' target price for which you would like Satsuma Pharmaceuticals odds to be computed.

Satsuma Pharmaceuticals Target Price Odds to finish over 1.10

The tendency of Satsuma Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 1.10 90 days 1.10 
about 14.2
Based on a normal probability distribution, the odds of Satsuma Pharmaceuticals to move above the current price in 90 days from now is about 14.2 (This Satsuma Pharmaceuticals probability density function shows the probability of Satsuma Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days Satsuma Pharmaceuticals has a beta of -0.64. This usually implies as returns on the benchmark increase, returns on holding Satsuma Pharmaceuticals are expected to decrease at a much lower rate. During a bear market, however, Satsuma Pharmaceuticals is likely to outperform the market. Additionally Satsuma Pharmaceuticals has an alpha of 0.5807, implying that it can generate a 0.58 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Satsuma Pharmaceuticals Price Density   
       Price  

Predictive Modules for Satsuma Pharmaceuticals

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Satsuma Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Satsuma Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
1.101.101.10
Details
Intrinsic
Valuation
LowRealHigh
0.840.841.21
Details
Naive
Forecast
LowNextHigh
1.211.211.21
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
1.091.101.11
Details

Satsuma Pharmaceuticals Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Satsuma Pharmaceuticals is not an exception. The market had few large corrections towards the Satsuma Pharmaceuticals' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Satsuma Pharmaceuticals, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Satsuma Pharmaceuticals within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
0.58
β
Beta against Dow Jones-0.64
σ
Overall volatility
0.14
Ir
Information ratio 0.04

Satsuma Pharmaceuticals Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Satsuma Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Satsuma Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Satsuma Pharmaceuticals is not yet fully synchronised with the market data
Satsuma Pharmaceuticals may become a speculative penny stock
Satsuma Pharmaceuticals has a very high chance of going through financial distress in the upcoming years
Net Loss for the year was (70.06 M) with profit before overhead, payroll, taxes, and interest of 0.
Satsuma Pharmaceuticals currently holds about 68.06 M in cash with (51.52 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.15, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Roughly 58.0% of the company shares are owned by institutional investors

Satsuma Pharmaceuticals Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Satsuma Stock often depends not only on the future outlook of the current and potential Satsuma Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Satsuma Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding32 M
Cash And Short Term Investments52.5 M

Satsuma Pharmaceuticals Technical Analysis

Satsuma Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. Satsuma Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Satsuma Pharmaceuticals. In general, you should focus on analyzing Satsuma Stock price patterns and their correlations with different microeconomic environments and drivers.

Satsuma Pharmaceuticals Predictive Forecast Models

Satsuma Pharmaceuticals' time-series forecasting models is one of many Satsuma Pharmaceuticals' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Satsuma Pharmaceuticals' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Satsuma Pharmaceuticals

Checking the ongoing alerts about Satsuma Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Satsuma Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Satsuma Pharmaceuticals is not yet fully synchronised with the market data
Satsuma Pharmaceuticals may become a speculative penny stock
Satsuma Pharmaceuticals has a very high chance of going through financial distress in the upcoming years
Net Loss for the year was (70.06 M) with profit before overhead, payroll, taxes, and interest of 0.
Satsuma Pharmaceuticals currently holds about 68.06 M in cash with (51.52 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.15, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Roughly 58.0% of the company shares are owned by institutional investors
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Consideration for investing in Satsuma Stock

If you are still planning to invest in Satsuma Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Satsuma Pharmaceuticals' history and understand the potential risks before investing.
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Equity Valuation
Check real value of public entities based on technical and fundamental data
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas